Coexistence of tet(A) and blaKPC-2 in the ST11 hypervirulent tigecycline- and carbapenem-resistant Klebsiella pneumoniae isolated from a blood sample
Tigecycline
Medical microbiology
Carbapenem
DOI:
10.1007/s10096-022-04512-6
Publication Date:
2022-11-02T07:02:31Z
AUTHORS (9)
ABSTRACT
Carbapenem-resistant Klebsiella pneumoniae are distributed worldwide. This study aimed to characterize a hypervirulent tigecycline-resistant and carbapenem-resistant strain, XJ-K2, collected from patient's blood. We tested antimicrobial susceptibility, virulence, whole-genome sequencing (WGS) on strain XJ-K2. WGS data were used identify virulence resistance genes perform multilocus sequence typing (MLST) phylogenetic analysis. Three novel plasmids, including pLVPK-like plasmid (pXJ-K2-p1) two multiple plasmids (pXJ-K2-KPC-2 pXJ-K2-p3), discovered in The IncFII(pCRY) pXJ-K2-p3 carried the dfrA14, sul2, qnrS1, blaLAP-2, tet(A) genes. IncFII(pHN7A8)/IncR pXJ-K2-KPC-2 also range of elements, containing rmtB, blaKPC-2, blaTEM-1, blaCTX-M-65, fosA3. MLST analysis revealed that XJ-K2 belonged type 11 (ST11). Seven complete phage sequences many found Meanwhile, susceptibility tests G. mellonella larval infection models confirmed extensively drug (XDR) hypervirulence KJ-K2. To our knowledge, this is first observation description ST11 tigecycline- K. co-carrying blaKPC-2 blood China. Further investigation needed understand mechanisms significant strain.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....